Literature DB >> 18428344

Mutation nomenclature.

Johan T den Dunnen1, Stylianos E Antonarakis.   

Abstract

As part of the Human Genome Variation Society (formerly known as the HUGO Mutation Database Initiative), a committee was formed to suggest standards for the description of sequence variants in DNA, RNA, and protein sequences. The committee proposed that the nomenclature should be unequivocal, precise, and short, and should prevent any possible confusion and follow existing practice as much as possible. To "spread the word," the nomenclature rules were published at regular intervals. This unit summarizes these nomenclature recommendations, which stimulated a uniform and unequivocal description of sequence variants in literature.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 18428344     DOI: 10.1002/0471142905.hg0713s37

Source DB:  PubMed          Journal:  Curr Protoc Hum Genet        ISSN: 1934-8258


  14 in total

1.  Novel WDR72 mutation and cytoplasmic localization.

Authors:  S-K Lee; F Seymen; K-E Lee; H-Y Kang; M Yildirim; E Bahar Tuna; K Gencay; Y-H Hwang; K H Nam; R J De La Garza; J C-C Hu; J P Simmer; J-W Kim
Journal:  J Dent Res       Date:  2010-10-11       Impact factor: 6.116

2.  Hirschsprung's disease and variants in genes that regulate enteric neural crest cell proliferation, migration and differentiation.

Authors:  Tonia C Carter; Denise M Kay; Marilyn L Browne; Aiyi Liu; Paul A Romitti; Devon Kuehn; Mary R Conley; Michele Caggana; Charlotte M Druschel; Lawrence C Brody; James L Mills
Journal:  J Hum Genet       Date:  2012-05-31       Impact factor: 3.172

3.  Analysis of PALB2 in a cohort of Italian breast cancer patients: identification of a novel PALB2 truncating mutation.

Authors:  Maria Teresa Vietri; Gemma Caliendo; Concetta Schiano; Amelia Casamassimi; Anna Maria Molinari; Claudio Napoli; Michele Cioffi
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

4.  High-resolution melt as a screening method in autosomal dominant polycystic kidney disease (ADPKD).

Authors:  Grazia Maria Virzì; Alice Bruson; Valentina Corradi; Fiorella Gastaldon; Massimo de Cal; Marta Donà; Dinna N Cruz; Maurizio Clementi; Claudio Ronco
Journal:  J Clin Lab Anal       Date:  2014-03-22       Impact factor: 2.352

5.  Towards a complete resolution of the genetic architecture of disease.

Authors:  Andrew B Singleton; John Hardy; Bryan J Traynor; Henry Houlden
Journal:  Trends Genet       Date:  2010-10       Impact factor: 11.639

6.  A highly sensitive genetic protocol to detect NF1 mutations.

Authors:  María Carmen Valero; Yolanda Martín; Elisabete Hernández-Imaz; Alba Marina Hernández; Germán Meleán; Ana María Valero; Francisco Javier Rodríguez-Álvarez; Dolores Tellería; Concepción Hernández-Chico
Journal:  J Mol Diagn       Date:  2011-03       Impact factor: 5.568

7.  THAP1 mutations (DYT6) are an additional cause of early-onset dystonia.

Authors:  H Houlden; S A Schneider; R Paudel; A Melchers; P Schwingenschuh; M Edwards; J Hardy; K P Bhatia
Journal:  Neurology       Date:  2010-03-09       Impact factor: 9.910

8.  Role of the DLGAP2 gene encoding the SAP90/PSD-95-associated protein 2 in schizophrenia.

Authors:  Jun-Ming Li; Chao-Lin Lu; Min-Chih Cheng; Sy-Ueng Luu; Shih-Hsin Hsu; Tsung-Ming Hu; Hsin-Yao Tsai; Chia-Hsiang Chen
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

9.  Extraction of human kinase mutations from literature, databases and genotyping studies.

Authors:  Martin Krallinger; Jose M G Izarzugaza; Carlos Rodriguez-Penagos; Alfonso Valencia
Journal:  BMC Bioinformatics       Date:  2009-08-27       Impact factor: 3.169

10.  PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine.

Authors:  Alice R Gardiner; Kailash P Bhatia; Maria Stamelou; Russell C Dale; Manju A Kurian; Susanne A Schneider; G M Wali; Tim Counihan; Anthony H Schapira; Sian D Spacey; Enza-Maria Valente; Laura Silveira-Moriyama; Hélio A G Teive; Salmo Raskin; Josemir W Sander; Andrew Lees; Tom Warner; Dimitri M Kullmann; Nicholas W Wood; Michael Hanna; Henry Houlden
Journal:  Neurology       Date:  2012-10-17       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.